A machine learning-enhanced intervention did not significantly outperform an active control (p > 0.05), though both significantly improved pain, depression, and quality of life (p < 0.001).
Does the CAI program improve pain, symptom burden, depression, and quality of life in Asian American breast cancer survivors compared to the CAPA program?
A machine learning-augmented web-based intervention did not significantly outperform a standard web-based intervention for pain and depression in Asian American breast cancer survivors, though both improved outcomes over time.
Absolute Event Rate: 0% vs 0%
Abstract Background: Asian American breast cancer survivors face additional cultural, linguistic, and access barriers that impede optimal pain self-management and timely mental-health care. These challenges underscore the need for culturally responsive, scalable interventions. Building on preliminary Cancer Pain Management Program (CAPA) work, we developed the Cancer Pain Management: A Technology-Based Intervention Program (CAI) that augments CAPA with depression-focused components for survivors reporting depressive symptoms and a machine learning feature for individualized support. Methods: As part of an ongoing randomized controlled trial, 106 Asian American women with a history of breast cancer were randomized: 58 to the intervention group and 48 to the active control group. The intervention group used the CAI and the active control group used the CAPA. CAI and CAPA were culturally tailored, multi-component, web-based interventions identical in structure, except CAI included depression-focused content and machine learning-driven personalization. Primary outcomes included pain (Cancer Pain Management CPM, Brief Pain Inventory-short form BPI-SF), symptom burden (Memorial Symptom Assessment Scale-Short Form: MSAS-SF), depression (Center for Epidemiologic Studies Depression Scale: CES-D), and quality of life (Functional Assessment of Cancer Therapy Scale-Breast Cancer: FACT-B). Assessments occurred at baseline (T0), 1 month (T1), and 3 months (T2). Mixed-effects growth models tested group, time, and interaction effects. Results: At baseline, groups were well balanced; no significant differences were observed in sociodemographic variables, breast cancer-related characteristics, or primary outcome measures (all p 0.05). Significant improvements over time were observed for pain (BPI-SF, p 0.001), depression (CES-D, p 0.001), and quality of life (FACT-B, p 0.001). However, no significant group or group-by-time interaction effects emerged (all p 0.05), indicating that CAI did not outperform CAPA despite its machine learning component. Conclusion: Both interventions improved outcomes over time; however, CAI, which incorporated machine learning-driven individualization, showed greater improvements than CAPA, although these differences were not statistically significant. These findings highlight the need for further research to evaluate and optimize personalization strategies using machine learning. Citation Format: Wonshik Chee, Jiwon Baek, Dongmi Kim, Seulgi Ryu, Yeeun Kim, Eun-Ok Im. Enhancing individualized interventions with machine learning: A better approach abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1227.
Chee et al. (Fri,) reported a other. A machine learning-enhanced intervention did not significantly outperform an active control (p > 0.05), though both significantly improved pain, depression, and quality of life (p < 0.001).